nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Backhanded Approach to Relieving Radial Artery Occlusion
|
Reddy, Revati |
|
|
38 |
6 |
p. 1089-1090 |
artikel |
2 |
A Mitochondrial Basis for Heart Failure Progression
|
Watson, William D. |
|
|
38 |
6 |
p. 1161-1171 |
artikel |
3 |
A Novel Parallel Wire-based Antegrade Dissection Re-entry Technique for Failed Retrograde Attempt of Coronary Chronic Total Occlusions with Risk Nomogram Analysis
|
Ma, Yuanji |
|
|
38 |
6 |
p. 1337-1348 |
artikel |
4 |
Can We Leave No Metal Behind? DCB vs. DES in Large Coronary Arteries
|
Lian, Grace |
|
|
38 |
6 |
p. 1077-1078 |
artikel |
5 |
Clopidogrel: Drug of the Past or Drug of the Future?
|
De Servi, Stefano |
|
|
38 |
6 |
p. 1073-1076 |
artikel |
6 |
Combining Forces: a New Variation in Antegrade CTO-PCI Technique
|
Alqam, Bilal |
|
|
38 |
6 |
p. 1091-1093 |
artikel |
7 |
Comparison of Efficacy and Safety Between Drug-Coated Balloons Versus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions in Large Vessels: A Study-Level Meta-Analysis of Randomized Control Trials
|
Sun, Bing |
|
|
38 |
6 |
p. 1375-1384 |
artikel |
8 |
CTRP5 Attenuates Doxorubicin-Induced Cardiotoxicity Via Inhibiting TLR4/NLRP3 Signaling
|
Zhang, Zhaoxia |
|
|
38 |
6 |
p. 1235-1244 |
artikel |
9 |
CYP2C19 Genotype-Guided Antiplatelet Therapy in Stroke Patients—Is It Ready for Prime Time?
|
Shao, Danwei |
|
|
38 |
6 |
p. 1079-1081 |
artikel |
10 |
Development and Validation of a Nomogram Model Affecting the ACT Targeting Rate During Radiofrequency Ablation of Atrial Fibrillation in China
|
Tang, Shiyun |
|
|
38 |
6 |
p. 1201-1214 |
artikel |
11 |
Does One Size Fits All?
|
Roldan, Vanessa |
|
|
38 |
6 |
p. 1099-1101 |
artikel |
12 |
Dual Versus Mono Antiplatelet Therapy in Patients with Acute Mild-to-Moderate Stroke: A Multicentre Perspective Cohort Study
|
Zhang, Kaili |
|
|
38 |
6 |
p. 1259-1270 |
artikel |
13 |
Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population
|
Osataphan, Nichanan |
|
|
38 |
6 |
p. 1327-1335 |
artikel |
14 |
How Much Is Enough?
|
Birnbaum, Yochai |
|
|
38 |
6 |
p. 1095-1097 |
artikel |
15 |
Immunotherapy in the Context of Aortic Valve Diseases
|
Bartoli-Leonard, Francesca |
|
|
38 |
6 |
p. 1173-1185 |
artikel |
16 |
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies
|
Cargnin, Sarah |
|
|
38 |
6 |
p. 1397-1407 |
artikel |
17 |
Inhibition of PCSK9 Improves the Development of Pulmonary Arterial Hypertension Via Down-Regulating Notch3 Expression
|
Ye, Peng |
|
|
38 |
6 |
p. 1223-1234 |
artikel |
18 |
Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine
|
Jiang, Leyu |
|
|
38 |
6 |
p. 1139-1159 |
artikel |
19 |
Intervention of Tanshinone IIA on the PGK1-PDHK1 Pathway to Reprogram Macrophage Phenotype After Myocardial Infarction
|
Gao, Shan |
|
|
38 |
6 |
p. 1359-1373 |
artikel |
20 |
Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation
|
Rutledge, Cody |
|
|
38 |
6 |
p. 1289-1302 |
artikel |
21 |
Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation
|
Li, Xiaoye |
|
|
38 |
6 |
p. 1315-1325 |
artikel |
22 |
Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction
|
Tannous, Cynthia |
|
|
38 |
6 |
p. 1385-1396 |
artikel |
23 |
Novel Drug Targets for Atrial Fibrillation Identified Through Mendelian Randomization Analysis of the Blood Proteome
|
Ning, Zuodong |
|
|
38 |
6 |
p. 1215-1222 |
artikel |
24 |
Preliminary Study on Retrograde Recanalization of Radial Artery Occlusion Through Distal Radial Artery Access: a Single-Center Experience
|
Wang, Huanhuan |
|
|
38 |
6 |
p. 1303-1313 |
artikel |
25 |
Reading Tea Leaves: Epigallocatechin-3-Gallate for Targeting Atrial Fibrosis
|
Adeleye, Adeniyi Gbenga |
|
|
38 |
6 |
p. 1189-1190 |
artikel |
26 |
Reducing Cardiovascular Disease—An Alternative Approach
|
Boricha, Hetal |
|
|
38 |
6 |
p. 1083-1087 |
artikel |
27 |
Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies—Analysis of the WHO Pharmacovigilance Database
|
Roule, Vincent |
|
|
38 |
6 |
p. 1191-1199 |
artikel |
28 |
Rivaroxaban Combined with Atorvastatin Inhibits Acute Pulmonary Embolism by Promoting the Expression of NRF2/NQO1
|
Chen, Yang |
|
|
38 |
6 |
p. 1271-1287 |
artikel |
29 |
SR-B1-/-ApoE-R61h/h Mice Mimic Human Coronary Heart Disease
|
Staršíchová, Andrea |
|
|
38 |
6 |
p. 1123-1137 |
artikel |
30 |
Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction
|
Li, Ming |
|
|
38 |
6 |
p. 1187-1188 |
artikel |
31 |
The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials
|
Sayed, Ahmed |
|
|
38 |
6 |
p. 1415-1420 |
artikel |
32 |
The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
|
Zhang, Shuang |
|
|
38 |
6 |
p. 1349-1358 |
artikel |
33 |
The Efficacy and Safety of Patiromer for Heart Failure Patients: A Systematic Review and Meta-Analysis
|
Wang, Yuhui |
|
|
38 |
6 |
p. 1245-1257 |
artikel |
34 |
The Role of Small Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Myocardial Protection: a Review of Current Advances and Future Perspectives
|
Wu, Hongkun |
|
|
38 |
6 |
p. 1111-1122 |
artikel |
35 |
Ticagrelor and Statins: Dangerous Liaisons?
|
Rocca, Bianca |
|
|
38 |
6 |
p. 1103-1109 |
artikel |
36 |
Uncovering the Relationship Between Statins and Muscle Problems in the ELSA-Brasil MSK Cohort
|
Pedroso, Aline Fernandes |
|
|
38 |
6 |
p. 1409-1414 |
artikel |